Google Search

Search

Already a Member ?

Best Business Opportunities in Sikkim - Identification and Selection of right Project, Thrust areas for Investment, Industry Startup and Entrepreneurship Projects

Sikkim is an Indian state situated in the Himalayas and is known to be landlocked. It is the least populous state in the country and the second smallest in area after Goa. In the past few years, the Sikkim Government has tried its level best to promote tourism in the state and has been successful in its task as well. The world's third highest mountain, Mt. Kanchenjunga, dominates this tiny Himalayan State with its beauty and majesty. The State is one of the 18 biodiversity hotspots in the world. It includes nearly one third of the total species of angiosperm found in the country; around 4,000 species of flowering plants; 300 species of ferns and allies; 144 species of mammals; 500 to 600 species of birds and so on. Rare Blue Sheep, Tibetan Mastiff, Yaks and Red Pandas are also found here. Such natural beauty along with ideal climatic condition of the State augurs well for the tourism industry. The green image of the State has made it an attractive investment destination.

It is a popular tourist destination owing to its culture, scenery and biodiversity. Kanchenjunga the world’s 3rd highest peak is the state’s highest point. The state’s economy is largely agrarian based on the terraced farming of rice, it also produces more cardamom than any other Indian state and is home to the largest cultivated area of cardamom. It lacks a large scale industrial base, brewing, distilling, tanning and watch making are the main industries. Noodle based dishes such as thukpa and chowmein are common, it is also the 3rd highest per capita alcoholism rate amongst all Indian states.

In Sikkim, agriculture is the main occupation of the inhabitants. Agriculture in Sikkim seems to be the basis of the socio-cultural pattern of the territory.

Sikkim is blessed by a fertile land that largely supports agriculture. The topography and the climatic condition of Sikkim is favorable for agriculture at Sikkim. Therefore, Sikkim witnesses a high yield every year. Among the chief crops grown in Sikkim are:

Wheat

Paddy

Maize

Barley

Buck wheat

Cardamom

Potatoes

Tea, etc.

It is noteworthy that Sikkim produces the highest amount of Cardamom in India. Sikkim is also known for housing the largest area of Cardamom field within the territory. Cardamom is among the two cash crops of Sikkim, besides potato. Sikkim is known for producing a special variety of tea that is known for its taste and quality throughout the world. One might come across a number of tea estates in Sikkim that form an integral part of Sikkim agriculture.

The important mineral resources of the state are copper-lead-zinc and silver reported in Bhotang, Rangpo and Dikchu in East Sikkim district. Occurrences of other minerals like dolomite, quartzite and steatite are reported in West Sikkim district. Limestone in North Sikkim district and Marble in East Sikkim and North Sikkim districts.

·         Bamboo and Cane Craft are deep rooted in traditional culture of the state.

·         Producer of Carpets of varied designs and high quality.

·         Handloom Products are famous for their beauty and intricate design.

·         Apparel and Garment making Unit at Barfok.

·         Carpet weaving at Makha.

·         Candle making at Namchi.

The above mentioned points proves that Northeast India has the potential to produce the country’s finest silk products, the same of which can be exported outside the country, elevating the economic standard and status of the Northeastern states besides putting Northeast in the cultural map of the world.

We can provide you detailed project reports on the following topics. Please select the projects of your interests.

Each detailed project reports cover all the aspects of business, from analysing the market, confirming availability of various necessities such as plant & machinery, raw materials to forecasting the financial requirements. The scope of the report includes assessing market potential, negotiating with collaborators, investment decision making, corporate diversification planning etc. in a very planned manner by formulating detailed manufacturing techniques and forecasting financial aspects by estimating the cost of raw material, formulating the cash flow statement, projecting the balance sheet etc.

We also offer self-contained Pre-Investment and Pre-Feasibility Studies, Market Surveys and Studies, Preparation of Techno-Economic Feasibility Reports, Identification and Selection of Plant and Machinery, Manufacturing Process and or Equipment required, General Guidance, Technical and Commercial Counseling for setting up new industrial projects on the following topics.

Many of the engineers, project consultant & industrial consultancy firms in India and worldwide use our project reports as one of the input in doing their analysis.

We can modify the project capacity and project cost as per your requirement.
We can also prepare project report on any subject as per your requirement.

Page 131 of 221 | Total 2201 projects in this category
« Previous   Page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 .... 131 220 221   Next »

Add multiple items to inquiry
Select the items and then press Add to inquiry button

Select all | Clear all Sort by

A4 and A3 Size Paper

Paper is often characterized by weight. In the United States, the weight assigned to a paper is the weight of a ream, 500 sheets, of varying "basic sizes", before the paper is cut into the size it is sold to end customers. For example, a ream of 20 lb, 8.5 in × 11 in (216 mm × 279 mm) paper weighs 5 pounds, because it has been cut from a larger sheet into four pieces. In the United States, printing paper is generally 20 lb, 24 lb, or 32 lb at most. Cover stock is generally 68 lb, and 110 lb or more is considered card stock. In Europe, and other regions using the ISO 216 paper sizing system, the weight is expressed in grammes per square metre (g/m2 or usually just g) of the paper. Printing paper is generally between 60 g and 120 g. Anything heavier than 160 g is considered card. The weight of a ream therefore depends on the dimensions of the paper and its thickness. These are normal printer papers commonly referred to as copy paper. They are used to print documents in which there is no or little use of graphics. They certainly do not support high res image printing. A4 is not only used as printing stationery in printer or copier from output of a page on computer. It is also used as international size for all sort of documents, like letters,forms,bit notice,posters, catalogues, magazines, In Engineering A4 size paper is the mostly used as hard copy of drawing or document in a handy way. Most commercial paper sold in North America is cut to standard paper sizes based on customary units and is defined by the length and width of a sheet of paper. The global cut size uncoated freesheet paper market was valued at $16,122.3 million in 2017 and is projected to reach $18,483.6 million by 2023, witnessing a CAGR of 2.4% during the forecast period. The growth of the paper industry in emerging economies and advantages associated with the use of uncoated sheet paper are driving the market growth. Cut size uncoated freesheet paper is a type of graphic paper manufactured using about 90.0% chemical pulp and 10.0% mechanical pulp. The product is available in the form of rectangular sheets in three sizes: 210 mm x 297 mm (A4), 297 mm x 420 mm (A3), and 215 mm x 345 mm (legal). Few Indian major players are as under Bajaj Kagaj Ltd. Bindals Papers Mills Ltd. Brijlaxmi Paper Products Pvt. Ltd. Chadha Papers Ltd.
Plant capacity: A4 (80 gsm) Size Paper:400 Packets / day A3 (75 gsm) Size Paper:300 Packets / dayPlant & machinery: Rs 19 lakhs
Working capital: -T.C.I: Cost of Project:Rs 60 lakhs
Return: 32.00%Break even: 70.00%
Add to Inquiry Add to Inquiry Basket

Spice Powder (Turmeric, Chilli, Pepper, Coriander and Cumin Powder)

Spices are woven into the history of nations. The desire to possess and monopolize the spice trade has, in the past, compelled manynavigators to find new routes to spice-producing nations. In the late 13thcentury, Marco Polo’s exploration of Asia established Venice as the most important trade port. Venice remained prosperous until about 1498. Portuguese explorer Vasco da Gama sailed around Africa’s Cape of Good Hope to reach Calicut, India. He returned with pepper, cinnamon, ginger and jewels, and also deals for the Portuguese to continue trade with India. India, known as the home of spices, boasts a long history of trading with the ancient civilisations of Rome and China. Today, Indian spices are the most sought-after globally, given their exquisite aroma, texture, taste and medicinal value. India has the largest domestic market for spices in the world. Traditionally, spices in India have been grown in small land holdings, with organic farming gaining prominence in recent times. India is the world's largest producer, consumer and exporter of spices; the country produces about 75 of the 109 varieties listed by the International Organization for Standardization (ISO) and accounts for half of the global trading in spices. Chilly is the largest produced spice in India. It contributed to the tune of ~% of the world production. This spice is used majorly in curried cuisines. It is also used in curry power, seasoning and other such spice mixes. MDH was the dominating player in FY’2015, with a market share of ~% in the total revenues generated from the sales of spices in the organized segment. The major factor for the dominance of MDH is the gigantic distribution network comprising of 1,000 wholesalers and more than 400,000 retailers in India. The Indian spices market is pegged at Rs. 40,000 crore annually, of which the branded segment makes up 15 per cent. According to Technopak, the branded space is dominated by national brands such as Catch, Everest, Ramdev, among others. The population in India is surging and the increasing consumer expenditure on food explains the swelling demand for food in India. Accordingly, the demand for spices is expected to grow in the future which will lead to a prominent growth in the revenues from the sales of spices in India. The revenues from India market are expected to expand to around USD 18 billion in FY’2020, growing with a CAGR of ~% from FY’2016 to FY’2020. The highest contribution to this growth is expected to come from the spice mixes and blended spices. The Indian spices market is worth INR 40,000 crore annually. Key spices produced in the country include pepper, cardamom, chilli, ginger, turmeric, coriander, cumin, celery, fennel, fenugreek, ajwain, dill seed, garlic, tamarind, clove, and nutmeg among others. The market is largely unorganized and the branded segment makes up about 15%. The branded market is dominated by players such as MTR, Badshaah, Catch, Everest, Ramdev etc. Recently, Tata Chemicals has launched its spices brand Tata Sampann Spices. Few Indian major players are as under A V T Mccormick Ingredients Pvt. Ltd. Akay Spices Pvt. Ltd. Bhavani Tea & Produce Co. Ltd. Cookme B B D Pvt. Ltd. D T A Amalgamated Foods Pvt. Ltd. Devon Foods Ltd. MDH Spices Oregon Spice Company
Plant capacity: Turmeric Powder :100.0 Kgs / day Red Chilli Powder:100.0 Kgs /day Pepper Powder: 100.0 Kgs / day Coriander Powder: 100.0 Kgs / day Cumin Powder:100.0 Kgs / dayPlant & machinery: Rs 12 lakhs
Working capital: -T.C.I: Cost of Project : Rs 38 lakhs
Return: 30.00%Break even: 75.00%
Add to Inquiry Add to Inquiry Basket

Skill Development Centre

The role of education in facilitating social and economic progress has long been recognized. Education improves functional and analytical ability and there by opens up opportunities for individuals and also groups to achieve greater access to labour markets and livelihoods. A better educated labour force is essential if we are to meet the labour supply requirements of faster growth. Education is not only an instrument of enhancing efficiency but is also an effective tool of widening and augmenting democratic participation and upgrading the overall quality of individual and societal life. India’s population is huge at 1.21 billion. It is fast expanding at a rate of 17% and integrating rapidly into the global economy. India is among the ‘young’ countries in the world, with the proportion of the work force in the age group of 15-59 years, increasing steadily. However, presently only 2% of the total workforce in India have undergone skills training. India has a great opportunity to meet the future demands of the world, India can become the worldwide sourcing hub for skilled workforce. The challenges for India get magnified, as it needs to reach out to the million plus workforce ready population, while facing an ever increasing migration of labour from agriculture to manufacturing and services. With the government launching a number of schemes to empower the young workforce, the challenges magnify as there is a need for effective implementation of the schemes at the grass root level with equal participation from all the stakeholders concerned. India is one of the youngest nations in the world with more than 54% of the total population below 25 years of age. India is one of the youngest nations in the world with more than 54% of the total population below 25 years of age. India’s workforce is the second largest in the world after China’s. While China’s demographic dividend is expected to start tapering off by 2015, India will continue to enjoy it till 2040. However, India’s formally skilled workforce is approximately 2% - which is dismally low compared to China (47%), Japan (80%) or South Korea (96%).To leverage our demographic dividend more substantially and meaningfully, the Government launched the “Skill India” campaign along with “Make in India”. In this brief, we look at the Skill Development ecosystem in India - the need for Skill Development, initiatives taken by the Government and schemes introduced for skill government by the present government. India’s workforce is the second largest in the world after China’s. While China’s demographic dividend is expected to start tapering off by 2015, India will continue to enjoy it till 2040. However, India’s formally skilled workforce is approximately 2%- which is dismally low compared to China (47%), Japan (80%) or South Korea (96%).To leverage our demographic dividend more substantially and meaningfully, the Government launched the “Skill India” campaign along with “Make in India”. In this brief, we look at the Skill Development ecosystem in India - the need for Skill Development, initiatives taken by the Government and schemes introduced for skill government by the present government.
Plant capacity: Engineering Graduates: 250 Students / Batch Supervisory & Workmen Cadre:250 Students / Batch Each Batch 3 MonthPlant & machinery: Rs 291 lakhs
Working capital: -T.C.I: Cost of Project :Rs 1228 lakhs
Return: 15.00%Break even: 45.00%
Add to Inquiry Add to Inquiry Basket

Ladies Undergarment

Lingerie has been an intimate part of a woman’s life since long. Until the pre-1970 era, innerwear was viewed as an essential ‘commodity’ with no focus from any retailer. The market was highly fragmented and was dominated by local and unorganized brands. Unorganised MBOs dominated the innerwear market until the 1990s, after which there was an influx of Indian and foreign brands. Organised brands came up and there was a gradual increase in the demand for them. Between 2000 and 2008, premium international brands started foraying into the Indian market. Indian brands showcased new designs and styles to woo the new age Indian women. The focus was mainly on the width of the product range. Men’s and women’s innerwear began to be sold through a variety of retail formats such as EBOs, LFS and departmental stores. They are considered as an important garment among females for properly supporting and covering their sensitive body parts, it keeps them fit for daily general works. It also aids to improve the figure of ladies and hence it is used throughout the world. India lingerie market stood at around $ 3 billion in 2017 and is projected to grow at a robust CAGR of around 14% to reach $ 6.5 billion by 2023, on the back of growing demand for lingerie sets, rising middle class population and increasing number of financially independent women. Technical advancements in lingerie manufacturing, with a rising number of manufacturers using luxurious, delicate fabrics and designs such as mesh and lace, is also augment demand for lingerie products in the country. Growing e-commerce industry coupled with rising demand for premium brands are some of the other factors that are boosting lingerie sales in India during the forecast period. Few Indian major players are as under Bodycare International Ltd. Creative Casuals (India) Pvt. Ltd. Gokaldas Exports Ltd. H-Lon Hosiery Ltd. Juliet Apparels Pvt. Ltd. Lovable Lingerie Ltd. Otto Clothing Pvt. Ltd.
Plant capacity: Bra:800 Pcs. / day Panties:800 Pcs./dayPlant & machinery: Rs 67 lakhs
Working capital: -T.C.I: Cost of Project :Rs 124 lakhs
Return: 28.00%Break even: 66.00%
Add to Inquiry Add to Inquiry Basket

Cold Storage (Shrimp & Agricultural Products)

India is the largest producer, consumer and exporter of spices and spice products in the world and produces more than 50 spices. India is also a big exporter of Chilli, turmeric, cumin, pepper and many other spices. The country also imports various spices to meet its local requirement of taste as Indian dishes are incomplete without adding varieties of spices to them. Besides, quality of a sizable quantity of produce also deteriorates by the time it reaches the consumer. This is mainly because of perishable nature of the produce which requires a cold chain arrangement to maintain the quality and extend the shelf-life if consumption is not meant immediately after harvest. Ministry of Agriculture launched a “Mission for Integrated Development of Horticulture” in 2014, under which cold-chain development is the thrust area, so that all other inputs in way of enhancing horticultural yields can have suitable recourse toreach gainful end-use. This Mission subsumes all previous major programmes for horticulture (namely NHM, HMNEH, NHB, CDB, NBM, CIH) of the Department of Agriculture & Cooperation. India’s cold chain industry is still evolving, not well organized and operating below capacity. Most equipment in use is outdated and single commodity based. According to government estimates, India has 5,400 cold storage facilities, with a combined capacity of 23.66 million metric tons that can store less than 11% of what is produced. The majority of cold storage facilities are utilized for a single commodity, such as potatoes. Most of these facilities are located in the states of Uttar Pradesh, Uttaranchal, Punjab, Maharashtra, and West Bengal. The following table shows distribution of facilities by commodity. Indian cold storage market is expected to grow at a CAGR of 16.09% by 2020 driven by the growth in the organized retail, Indian fast food market, and food processing industry and e-commerce sectors. Cold storage market in India is expected to be worth US$ 8.57 billion by 2020. The estimated annual production of fruits and vegetables in the country is about 130 million tonnes. This accounts for 18% of our agricultural output. Due to diverse agro climatic conditions and better availability of package of practices, the production is gradually rising. Although, there is a vast scope for increasing the production, the lack of cold storage and cold chain facilities are becoming major bottle necks in tapping the potential. The cold storage facilities now available are mostly for a single commodity like potato, orange, apple, grapes, pomegranates, flowers, etc. which results in poor capacity utilization.
Plant capacity: Fruits, Vegetables and Shrimp Storage : 1000 MT Plant & machinery: Rs 286 lakhs
Working capital: -T.C.I: Cost of Project :Rs 553 lakhs
Return: 13.00%Break even: 59.00%
Add to Inquiry Add to Inquiry Basket

Atmanirbhar Bharat Abhiyan (Self-Reliant India Mission)

Atmanirbhar Bharat Abhiyan (Self-Reliant India Mission)—A Post-Pandemic Financial Package to Help Restore Economic Growth and Make India Self-Reliant. The vision of the Prime Minister of India Narendra Modi of making India a self-reliant nation. The first mention of this came in the form of the 'Atma Nirbhar Bharat Abhiyan ' or 'Self-Reliant India Mission' during the announcement of the coronavirus pandemic related economic package on 12 May 2020. As part of the Atma Nirbhar Bharat package, numerous government decisions have taken place such as changing the definition of MSMEs. Boosting scope for private participation in numerous sectors, increasing FDI in the Defence sector, and the vision has found support in many sectors such as the solar manufacturers sector. The special economic package would be the main component of 'Atma-Nirbhar Bharat (self-reliant India)' Modi said in his fifth address to the nation. “Corona will be with us for a long time but our lives cannot revolve around corona. The Prime Minister said emphasizing on migrant workers, several of whom lost their lives while trying to reach their native places during the lockdown. Some even staged protests demanding transport facility to their homes. RBI announced an Rs 3.4 lakh crore monetary stimulus. Modi’s Rs 20 lakh crore package will include all of that. The Prime Minister’s address came a day after he held a marathon six-hour meeting with chief ministers, with almost all of them asking for a large financial package. He said self-reliant India will stand on five pillars – Economy, infrastructure, tech-driven system, vibrant demography and demand. Prime Minister Modi, in his fifth address to the nation since the great lockdown announced 'Atma Nirbhar Bharat Abhiyan' package of Rs. 20 lakh crore to revive the Indian economy, to help farmers, migrant workers, etc. and to revive the industrial sector. This package is 10% of India's total GDP. The details about the package were announced by the Finance Minister Nirmala Sitharaman in 5 tranches. These tranches were announced by the Finance Minister via press conferences from May 13, 2020, to May 17, 2020. The package included Rs 8 lakh crore in liquidity measures announced by the RBI. The government will also provide a 100% guarantee to Rs 3 lakh crore in small business loans. MSMEs are provided with 6 relief measures under Atma Nirbhar Bharat Abhiyan Package-- Rs. 3 lakh crore Collateral-free loan to be provided (45 MSMEs will be benefitted), Government will infuse Rs. 20,000 Crores in the stressed MSMEs (2 lakh MSMEs will be benefitted), Government will provide a fund of Rs. 50,000 Crores to the MSMEs having potential growth, the new definition of MSMEs is given, Global tender is not allowed for government procurement up to Rs. 200 crore and local trade fairs are not possible. Atma Nirbhar Bharat has been called by some as a re-packaged version of the Make in India movement using new taglines such as 'Vocal for Local’. Other opposition members spoke about how India had enacted policies and built companies since its creation to make India self-reliant - SAIL for steel production, IITs for domestic engineers, AIIMS for medical science, DRDO for Defence research, HAL for aviation, ISRO for space, CCL NTPC and GAIL in the area of energy; criticizing the advertising tactics. Some have re-phrased it to "Fend for Yourself" Campaign. Also, the calls for India to boycott Chinese products (and promote an Atma Nirbhar Bharat instead), are practically difficult in the short term for India as India imports $75 billion worth of goods every year from China, to the extent that parts of Indian industry are dependent on China. Following the Galwan Valley skirmish on 15 June 2020 in which 20 Indian soldiers died, Swedish Jagran Manch said that if the government was serious about making India self-reliant, Chinese companies should not be given projects such as the Delhi-Meerut RRTS. Government Reforms Policy Highlights Increase in borrowing limits: The borrowing limits of state governments will be increased from 3% to 5% of Gross State Domestic Product (GSDP) for the year 2020-21. This is estimated to give states extra resources of Rs 4.28 lakh crore. There will be unconditional increase of up to 3.5% of GSDP followed by 0.25% increase linked to reforms on - universalization of ‘One Nation One Ration card’, Ease of Doing Business, power distribution and Urban Local Body revenues. Further, there will be an increase of 0.5% if three out of four reforms are achieved. Privatization of Public Sector Enterprise (PSEs): A new PSE policy has been announced with plans to privatize PSEs, except the ones functioning in certain strategic sectors which will be notified by the government. In strategic sectors, at least one PSE will remain, but private sector will also be allowed. To minimize wasteful administrative costs, number of enterprises in strategic sectors will ordinarily be only one to four; others will be privatized/ merged/ brought under holding companies. Measures for Businesses (Including MSMEs) Financial Highlights Collateral free loans for businesses: All businesses (including MSMEs) will be provided with collateral free automatic loans of up to three lakh crore rupees. MSMEs can borrow up to 20% of their entire outstanding credit as on February 29, 2020 from banks and Non-Banking Financial Companies (NBFCs). Borrowers with up to Rs 25 crore outstanding and Rs 100 crore turnover will be eligible for such loans and can avail the scheme till October 31, 2020. Interest on the loan will be capped and 100% credit guarantee on principal and interest will be given to banks and NBFCs. Corpus for MSMEs: A fund of funds with a corpus of Rs 10,000 crore will be set up for MSMEs. This will provide equity funding for MSMEs with growth potential and viability. Rs 50,000 crore is expected to be leveraged through this fund structure. Subordinate debt for MSMEs: This scheme aims to support to stress MSMEs which have Non-Performing Assets (NPAs). Under the scheme, promoters of MSMEs will be given debt from banks, which will be infused into the MSMEs as equity. The government will facilitate Rs 20,000 crore of subordinate debt to MSMEs. For this purpose, it will provide Rs 4,000 crore to the Credit Guarantee Fund Trust for Micro and Small Enterprises, which will provide partial credit guarantee support to banks providing credit under the scheme. Schemes for NBFCs: A Special Liquidity Scheme was announced under which Rs 30,000 crore of investment will be made by the government in both primary and secondary market transactions in investment grade debt paper of Non-Banking Financial Companies (NBFCs)/Housing Finance Companies (HFCs)/Micro Finance Institutions (MFIs). The central government will provide 100% guarantee for these securities. The existing Partial Credit Guarantee Scheme (PCGS) will be extended to partially safeguard NBFCs against borrowings of such entities (such as primary issuance of bonds or commercial papers (liability side of balance sheets)). The first 20% of loss will be borne by the central government. The PCGS scheme will facilitate liquidity worth Rs 45,000 Crores for NBFCs. Employee Provident Fund (EPF): Under the PM Garib Kalyan Yojana, the government paid 12% of employer and 12% of employee contribution into the EPF accounts of eligible establishments for the months of March, April and May. This will be continued for three more months (June, July and August). This is estimated to provide liquidity relief of Rs 2,500 crore to businesses and workers. Statutory PF contribution: Statutory PF contribution of both the employer and employee will be reduced from 12% to 10% each for all establishments covered by EPFO for next three months. This scheme will apply to workers who are not eligible for the 24% EPF support under PM Garib Kalyan Package and its extension. However, Central Public Sector Enterprises (CPSEs) and State Public Sector Units (PSUs) will continue to contribute 12% as employer contribution. Street vendors: A special scheme will be launched within a month to facilitate easy access to credit for street vendors. Under this scheme, bank credit will be provided to each vendor for an initial working capital of up to Rs 10,000. This is estimated to generate liquidity of Rs 5,000 crore. Key Measures Taken by Reserve Bank of India (RBI) The overall financial package that has been announced also includes the liquidity generated by measures announced by RBI. Some of these measures include: Cash Reserve Ratio (CRR) was reduced which resulted in liquidity support of Rs 1, 37, 000 crore. Banks’ limits for borrowing under the marginal standing facility (MSF) were increased. This allowed banks to avail additional Rs 1, 37,000 crore of liquidity at reduced MSF rate. Total Rs 1,50,050 crore of Targeted Long Term Repo Operations (TLTRO) has been planned for investment in investment grade bonds, commercial paper, non-convertible debentures including those of NBFCs and MFIs. Special Liquidity Facility (SLF) of Rs 50,000 crore was announced for mutual funds to provide liquidity support. Special refinance facilities worth Rs 50,000 crore were announced for NABARD, SIDBI and NHB at policy repo rate. A moratorium of three months has been provided on payment of installments and interest on working capital facilities for all types of loans. Social Sector Policy Highlights Public health: The investment in public health will be increased along with investment in grass root health institutions of urban and rural areas. The lab networks are being strengthened in districts and block levels for efficient management of the pandemic. The National Digital Health Blueprint will be implemented, which aims at creating an ecosystem to support universal health coverage in an efficient, inclusive, safe and timely manner using digital technology. Allocation for MGNREGS: To help boost rural economy, an additional Rs 40,000 crore will be allocated under MGNREGS. This increases the Union Budget allocation for MGNREGS from Rs 61,500 crore to Rs 1, 01, 500 crore (65% increase) for 2020-21. Viability Gap Funding: Viability Gap Funding (VGF) for social infrastructure projects will be increased by up to 30% of the total project cost. The total expense for developing the social infrastructure is estimated be Rs 8,100 crore. Technology driven education: PM e Vidya will be launched for multi-mode access to digital/online education. This program will include facilities to support school education in states/UTs under the DIKSHA scheme (one nation, one digital platform). National Foundational Literacy and Numeracy Mission will be launched by December 2020 to ensure that every child attains learning level and outcomes in grade 5 by 2025. Atma Nirbhar Bharat Abhiyan: Challenges Impact of this Stimulus Package Primary Sector: The measures (reforms to amend ECA, APMC, Contract framing, etc.) announced for the agricultural and allied sectors are particularly transformative. These reforms are steps towards the One Nation One Market objective and help India become the food factory of the world. These would finally help in achieving the goal of a self-sustainable rural economy. Also, the MGNREGA infusion of Rs 40,000 crore may help in alleviating the distress of migrants when they return to their villages. Secondary Sector: Given the importance of MSMEs for Indian economy, the Rs 3 lakh crore collateral-free loan facility for MSMEs under the package will help this finance-starved sector and thereby provide a kick start to the dismal state of the economy. Also, as the MSME sector is the second largest employment generating sector in India, this step will help to sustain the labour intensive industries and thereby help in leveraging India’s comparative advantage. Additionally, limiting imports of weapons and increasing the limit of foreign direct investment in Defence from 49% to 74% will give a much-needed boost to the production in the Ordnance Factory Board, while reducing India’s huge Defence import bill. Tertiary Sector: The government has adopted a balanced approach in addressing concerns across sectors. For example: The newly launched PM e-Vidya programme for multi-mode access to digital online education provides a uniform learning platform for the whole nation, which shall enable schools and universities to stream courses online without further loss of teaching hours. Public expenditure on health will be increased by investing in grass root health institutions and ramping up health and wellness centers in rural and urban areas. Aatmanirbhar Bharat Abhiyan Support Indian Economy in Fight against COVID-19 India has faced the COVID-19 situation with fortitude and a spirit of self-reliance that is evident in the fact that from zero production of Personal Protection Equipment (PPE) before March 2020, India today has created a capacity of producing 2 lakh PPE kits daily, which is also growing steadily. Additionally, India has demonstrated how it rises up to challenges and uncovers opportunities therein, as manifested in the re-purposing of various automobile sector industries to collaborate in the making of life-saving ventilators. The clarion call given by the Humble PM to use these trying times to become Atma Nirbhar (self-reliant) has been very well received to enable the resurgence of the Indian economy. The Five pillars of Atma Nirbhar Bharat focus on: Economy Infrastructure System Vibrant Demography and Demand The Five phases of Atma Nirbhar Bharat are: Phase-I: Businesses including MSMEs Phase-II: Poor, including migrants and farmers Phase-III: Agriculture Phase-IV: New Horizons of Growth Phase-V: Government Reforms and Enablers Finance Minister’s Top Announcements Regarding Economic Package for Aatmanirbhar Bharat Prime Minister Narendra Modi's strategy for the Aatmanirbhar Bharat was presented by the Finance Minister on Tuesday. Finance Minister made major announcements regarding, MSME, NBFC, TDS, TCS, and much more. ETBFSI has crafted Finance Minister's top 15 announcements. Collateral free automatic loans will now be available for MSMEs. This facility is of a total amount of Rs 3 lakh Crores. Those MSMEs whose turnover is 100 crore and have 25 crore outstanding loan exposure, are eligible for this facility. The tenor of this loan will be 4 years and a moratorium of 12 months will be provided to the MSMEs availing the offer. 100% credit guarantee on principal and interest will be provided by the government. Available till 31st October and will benefit 45 lakh units. No extra cost or fresh collateral will be required. Subordinate debt worth Rs 20,000 crore introduced for stressed MSMEs. Those companies which are stressed or even an NPA are eligible for this facility. 2 lakh MSMEs are likely to benefit from this. A Fund of funds is being created which will lead to an infusion of 50,000 crore as equity into MSMEs. Those who have potential and are viable companies will benefit from this. This will help them expand their capacities and get listed in the markets which they can choose. Definition of MSMEs being changed in flavour of their interest. Many of these firms fear that if they outgrow the designated size, they will lose their flavours. Now they do not need to worry about growing in size. Investment limit which defined an MSME is being revised upwards. An additional criteria is also being brought in based on turnover. Differentiation between manufacturing and service MSMEs is being removed and the necessary law amendments will be brought about soon. This is the new definition: Micro: Investment < 1 crore, Turnover < 5 crore Small: Investment < 10 crore, Turnover < 50 crore Medium: Investment < 20 crore, Turnover < 100 crore Global tenders will be disallowed in Govt procurement for tenders under Rs 200 crore. This will make MSMEs run their business with much more confidence. Self-reliant India will work hand in hand with Make in India as they will be allowed to participate in government purchases. No competition from foreign companies for tenders under Rs 200 crore. Ensuring that e-market linkage is provided to all MSMEs so that they can find their market in the absence of trade fairs. Within the next 45 days all their receivables will be cleared by the Govt of India and CPSEs. Liquidity relief is being given for EPF establishments. In the 12% of the employer-employee contribution that was being financed by the government under PMGKY, the centre will now extend the support which it gave earlier (from March-May) by another 3 months. 3.6 lakh establishments had benefited from this move. This amounts to an Rs 2,500 crore liquidity support from which 72 lakh employees are to benefit. Statutory PF contribution for those not covered in this earlier point will be reduced from 12 to 10% for the next 3 months. However, for centre and state enterprises, employers will continue to pay 12% but the employee will be given the benefit of paying only 10%. This equates to Rs 6,750 crore liquidity relief for next 3 months. It was duly noted that NBFCs weren't getting enough resources, especially the ones not that highly rated. For this reason, a 30,000 crore special liquidity scheme has now been introduced. The investment will be made in both primary and secondary market transactions in buying investment grade debt papers of NBFCs, MFIs and HFCs. These NBFCs are also funding MSMEs. Hence, this infusion of liquidity is absolutely necessary. This will also be fully guaranteed by the government of India. Aim is to ease the flow of credit for NBFCs who have a "not so good quality" of debt paper in their hands. A 45,000 crore liquidity infusion through Partial Credit Guarantee Scheme is also being done. This is an existing scheme but it is being expanded. First 20% loss will be borne by the government. Even unrated papers will be eligible for investment. This will specifically benefit many MFIs. DISCOMs are facing unprecedented cash flow problems. Hence, an emergency liquidity extension to the extent of 90,000 crore against all the receivables that they have is being introduced. PFCs and RECs will infuse this money. This will be done with guarantees being given by state governments. All GOI central agencies (Railways, Ministry of Road and Transport, Central Public Works Department, etc.) will now be providing a 6 months extension to contractors without any costs which will be covering construction work as well as goods and services contracts. They will partially release bank guarantees to the extent of partially completed contracts. The Ministry of Housing and Urban Affairs will be advising all states and UTs to treat COVID-19 as an event of 'Force Majeure' or in other words, an Act of God, under RERA. The registration and completion dates of all contracts expiring on or after March 25, 2020, will be extended suo-moto by 6 months. Fresh 'Project Registration Certificates' will be issued automatically with revised timelines. In an attempt to provide more funds to taxpayers, the rates of Tax Deduction at Source (TDS) for non-salaried specified payments made to residents and Tax Collection at Source (TCS) for the specified receipts will be reduced by 25%. This will come into effect from tomorrow till March 31, 2021, and will infuse liquidity worth Rs 50,000 crore into the system. All pending refunds to charitable trusts and non-corporate business & professions will be issued immediately. Due date of all income-tax returns will be extended from July 31, 2020 and October 31, 2020 to November 30, 2020. Tax audit dates extended from September 31, 2020 to October 31, 2020. Ease of Doing Business for MSMEs: The Micro, Small, and Medium Enterprises (MSMEs) sector is the most vibrant and dynamic industrial sector contributing significantly to the GDP and export while employing around 40 per cent of the Indian workforce. The Prime Minister’s speech emphasized that the MSME sector will act as the bedrock for economic revival. Intending to get the MSME sector back on its feet, the Prime Minister announced the MSME sector to be within the purview of the Atma-Nirbhar Bharat Abhiyan (ANBA). Subsequently, the Finance Minister announced six regulatory measures as part of the ANBA especially for the MSME sector, as part of a series of announcements by the government. In current times, where the mere survival of the MSME sector is at stake, ANBA intends to address the needs of the MSME sector and paves a path for long-term sustainability and profitability of MSMEs. First and foremost, revising the definition of MSME under applicable law is intended to bring more MSME enterprises under the purview of being classified as MSMEs so that they can reap benefits associated with it and grow under the watchful eyes. Under the new definition, the investment limit for micro, small and medium enterprises have been raised substantially and the distinction between manufacturing and services has been abolished. This measure will widen the net of benefits associated with classification as an MSME to more enterprises. Tags:- #MSME #MinistryofMicroSmallAndMediumEnterprises #SmallBusiness #msmebusiness #startup #MSMEproject #MSMEs #MSMEStartUp #MSMEtrade #MicroSmallMediumEnterprises #IndiaStartUp #MSMEindustry #AtmaNirbharBharatAbhiyan #AtmanirbharBharat #SelfreliantIndiaMission #CoronavirusLockdown #CoronavirusPandemic #AtmaNirbharBharatMission #AtmaNirbharBharat #MakeIndiaSelfReliant #DetailedProjectReport #businessconsultant #BusinessPlan #marketresearchreport #ProjectReportForBankLoan #entrepreneurship #NPCS #startupideas #startupbusinessideas #businessestostart #entrepreneurindia #profitablebusiness #IndustryTrends #InvestmentOpportunities #BusinessFeasibilityStudies
Plant capacity: -Plant & machinery: -
Working capital: -T.C.I: -
Return: 1.00%Break even: N/A
Add to Inquiry Add to Inquiry Basket

List of Items that are Mostly Imported from China, but can be Profitably Manufactured in India Itself

List of Items that are Mostly Imported from China, but can be Profitably Manufactured in India Itself. Business Opportunities for Indian Entrepreneurs. When the economical gap between India and China is narrowed, the country, prompted by emotions of nationalism amid the standoff between the two countries, can boycott Chinese products and carve out a path for 'Atma Nirbhar Bharat.' 'Made in China' label has over the years catapulted into every possible industry operating in India. This includes the well-known consumer durables comprising electronic goods, textile and garment industry, toys, medicines, car components but also encompass the Indian digital sector consisting of applications, OTT platforms, e-commerce companies and consumer fashion accessories etc. India should take steps forward to diversify productions, domestic manufacturing will help businesses to secure raw materials, and it can also make a global impact if everything is processed here, instead of outsourcing from China. India undoubtedly has the potential to become the next manufacturing destination for global companies. Top Products which India Imports from China are; 1. Electronics products 2. Organic Chemicals 3. Nuclear Machinery 4. Parts of computers 5. Cars and motorcycles parts 6. Toys 7. Fertilizers 8. Mobiles 9. Lightings 10. Milk products 11. Optical and medical instruments 12. Iron and steel The main goods imported from China include clocks and watches, musical instruments, toys, sports goods, furniture, mattresses, plastics, electrical machinery, electronic equipment, chemicals, iron and steel items, fertilisers, mineral fuel and metals. Related Projects: - Project Reports & Profiles According to government data, from March 2019 to February 2020, India imported $12.78 billion of capital goods from China, the second biggest category after electronics, televisions and electrical appliances ($18.12 billion). India’s total commodity import bill from China over the same period was $49 billion, according to the ministry of commerce. Industry was asked to send comments and suggestions on certain number of goods and raw materials imported from China, which include wrist watches, wall clocks, ampoules, glass rods and tubes, hair cream, hair shampoos, face powder, eye and lip make up preparations, printing ink, paints and varnishes, and some tobacco items, The government has recently put import restrictions on tyres, while also making its prior approval mandatory for foreign investments from countries that share land border with India to curb "opportunistic takeovers" of domestic firms, following Covid-19 pandemic, a move which will restrict FDI from China. India imported goods worth $62.4 billion, while exports to the neighboring country stood at $15.5 billion in the same period. The main goods imported from China include clocks and watches, musical instruments, toys, sports goods, furniture, mattresses, plastics, electrical machinery, electronic equipment, chemicals, iron and steel items, fertilizers, mineral fuel and metals. India has time and again raised concerns over widening trade deficit with China which stood at about $47 billion .Promote Atma Nirbhar Bharat (self-reliant India), including cut in import dependence from China. Export Opportunity: Supply Chain Shift Away from China Opportunity for Indian manufacturers are humongous if there is a sizeable shift in opportunities from China to India. A look at the India-USA trade gives some clue. A good portion of India’s current exports to the USA consist of apparel, pharma, chemicals, vehicles and furniture. However, except for a few sectors such as pharma, fish/sea creatures and carpets, exports from China are several times more than that of India. As per estimates, out of 1200-odd categories (HS-4 digit commodity classification) in which India exports to the US, there are 720 items where China caters to at least 10 percent of US imports. The point is to emphasise that the breadth of opportunity for India is huge. Even if 5 percent of US imports shift from China to India in these categories, the opportunity size is $140 billion. Look at countries beyond the US, China’s wallet share in the imports of countries such as Japan, Australia and European Union ranges from 22-25 percent. The gap between India and China in these markets is a bit higher. And so notwithstanding competition from Korea and Taiwan (high value-added products), and Vietnam, Bangladesh and Thailand (lower-end products), opportunity is huge. This would have a positive cascading effect on the economy as equivalent quantum of revenues would not only be added to the turnover of domestic enterprises including MSMEs but is also likely to translate to benefits through forward and backward linkages, better economies of scale along with cost competitiveness and importantly, enhancing the scope of employment generation. Related Books: - BOOKS & DATABASES India’s trade engagement is the fact that for a variety of reasons, India’s dependence on imports is getting to be localised, in the sense that there is not a wide diversification of countries from which India is sourcing its imports. For example, if you look at critical medical supplies which India has been importing for frontline healthcare workers in the COVID-19 battle, most of these come from China. China is one of the top sources but on the other hand, there isn’t a very widely diversified source of countries from which India can actually import these. This essentially means that aside from China, there are probably three or four countries of the world on which India's dependence is increasing. China is by and large widespread across different concentrations. To that extent, it’s going to be a difficult choice for India to get out of this dependence and search for alternative partners. Recently, the government announced an economic stimulus package of Rs 20 lakh crore and big-bang systemic reforms under the Atma Nirbhar Bharat Abhiyan (self-reliant India). The intended objective of this plan is two-fold. First, interim measures such as liquidity infusion and direct cash transfers for the poor will work as shock absorbers for those in acute stress. The second, long-term reforms in growth-critical sectors to make them globally competitive and attractive. Together, these steps may revive the economic activity, impacted by Covid-19 pandemic and create new opportunities for growth in sectors like agriculture, micro, small and medium enterprises (MSMEs), power, coal and mining, defence and aviation, etc. Measures for Businesses including MSME’s The Government along with the benefits to the business institutions and MSME have, have decided to revise the definition of MSME by changing the investment limits and introduced additional criteria of turnover. The revised definition would allow a broad coverage and benefits to more number of industries. Some of the benefits are as follows:- ? Collateral free automatic loans of INR 3 lakh Crores will be provided for Business, including MSME’s which are badly hit by the pandemic and requires new funding to meet operational liabilities, buy raw materials and restart business. Following benefits are provided under the collateral free loan scheme: ? Emergency Credit Line to Businesses/MSMEs from Banks and NBFCs up to 20 of entire outstanding credit as on February 29, 2020 ? Borrowers with up to INR 25 Crores outstanding and INR 100 Crores turnover eligible Measures for Businesses including MSME’s ? Loans to have 4 year tenor with moratorium of 12 months on principal repayment ? Interest to be capped ? 100 % credit guarantee cover to Banks and NBFC’s on principal and interest; and ? This scheme can be availed till October 2020. ? Global tender to be disallowed up to INR 200 Crores to benefit the MSME’s and other small institutions. ? Registration and completion date of Real Estate Projects under RERA shall be extended. ? INR 50,000 Crores liquidity to be given through reduction in TDS/TCS deductions. ? The government will facilitate provision of INR 20,000 Crores as subordinate debt for functioning MSMEs which are NPA or are stressed. ? Equity infusion of INR 50,000 Crores through Fund of Funds (FoF). The FOF with corpus of INR 10,000 Crores will be set up. The FoF will be operated through a Mother Fund and few daughter funds. The fund structure will help leverage INR 50,000 crore of funds at daughter funds level. It will help to expand MSME’s size as well as capacity. ? Fintech will be used to enhance transaction based lending using the data generated by the e-marketplace. ? MSME receivables from Government and CPSEs shall be released in 45 days. Atmanirbhar Bharat: With a special package PM has announced a special economic package and gave a clarion call for Self-reliant India. The package will provide a much-needed boost towards achieving self-reliance. This package, taken together with earlier announcements by the government during COVID crisis and decisions taken by RBI, is to the tune of Rs 20 lakh crore, which is equivalent to almost 10% of India’s GDP. The package will also focus on land, labour, liquidity and laws. It will cater to various sections including cottage industry, MSMEs, labourers, middle class, and industries, among others. Five Pillars of a Self-Reliant India PM iterated that a self-reliant India will stand on five pillars viz. 1) Economy, which brings in quantum jump and not incremental change 2) Infrastructure, which should become the identity of India 3) System, based on 21st-century technology-driven arrangements 4) Vibrant Demography, which is our source of energy for a self-reliant India and 5) Demand, whereby the strength of our demand and supply chain should be utilized to full capacity. What Did the RBI Provide Earlier? ? A rough estimate suggests that the RBI’s decisions have provided additional liquidity of Rs 5-6 lakh crore since the start of the Covid-19 crisis. ? Add this to the Rs 1.7 lakh crore of the first fiscal relief package announced by the Centre on March 26. Together, the two already account for 40 per cent of the Rs 20-lakh crore package. ? That leaves an effective amount of Rs 12 lakh crore. ? However, if the government is including RBI’s liquidity decisions in the calculation, then the actual fresh spending by the government could be considerably lower than Rs 12 lakh crore. ? That’s because RBI has been coming out with long term bond-buying operations (long term repo operation or LTRO, to infuse liquidity into the banking system) worth Rs 1 lakh crore at a time. ? If for argument’s sake, RBI comes out with another LTRO of Rs 1 lakh crore, then the overall fiscal help falls by the same amount. All MSME Benefits Announced in Atmanirbhar Bharat Abhiyan The growing clamour for fiscal support has led the government to introduce measures for MSMEs that have been hit by the lockdown. With a series of encouraging announcements, the Finance Minister outlined the government’s plan to raise the morale of the industry and the MSME sector in particular. Under the Atmanirbhar Bharat Abhiyan, the minister announced several measures for MSMEs that are expected to help 45 lakh business units resume their operations. Here are the key announcements for MSMEs. Credit guarantee of Rs 3 lakh crore: The massive increase in credit guarantees to MSMEs is the key highlight of the government’s relief package. The credit guarantee of 3 lakh crore by the government is intended to help MSMEs that have a 25 crore outstanding loan or less than 100 crore turnover. This provision will rescue MSMEs that need additional funding to meet operational liabilities and restart operations. The loans, which should be taken before October 31, 2020, will have a four year tenure and moratorium of 12 months. There is a 100% credit guarantee cover on principal and interest. The credit guarantee scheme is expected to help MSMEs survive the economic slowdown. Credit guarantees help banks meet the credit demand of MSMEs and provide an assurance that loans will be repaid by the government. Subordinate debt for NPA/stressed MSMEs: The government has set aside 20,000 crore as subordinate debt to help about two lakh MSMEs with stressed accounts or non-performing assets (NPA). Under this scheme, promoters of the MSME will be given debt, which will then be infused as equity in the unit. However, unlike credit guarantees, government support in this scheme is not full but partial. Revised definition: The government has changed the MSME definition to enable more businesses to benefit from incentives offered in the Atmanirbhar Bharat Abhiyan. The new definition of MSME, which had been on the government’s priority list for long, takes investment and annual turnover into consideration and does not differentiate between manufacturing and services. The ‘turnover’ based definition is seen as a better means of identifying MSMEs, particularly in services such as mid-sized hospitals and diagnostic centres. These will now be able to qualify for benefits offered to MSMEs. Experts suggest that the new definition would drive the growth of the MSME sector and help to make it self-reliant. Clearing of dues: While announcing the credit guarantee for MSMEs, the Finance Minister assured that the Centre would clear pending MSME dues in 45 days. As on March 31, 2020, the total outstanding payments to MSME units were estimated over 4.95 lakh crore. The Central Government ministries and departments, state governments and public sector units owe MSMEs more than half of this amount. Tags:- #AtmaNirbharBharatAbhiyan #AtmanirbharBharat #SelfreliantIndiaMission #CoronavirusLockdown #CoronavirusPandemic #AtmaNirbharBharatMission #AtmaNirbharBharat #MakeIndiaSelfReliant #DetailedProjectReport #businessconsultant #BusinessPlan #marketresearchreport #ProjectReportForBankLoan #entrepreneurship #NPCS #startupideas #startupbusinessideas #businessestostart #entrepreneurindia #profitablebusiness #IndustryTrends #InvestmentOpportunities #BusinessFeasibilityStudies #MSME #MinistryofMicroSmallAndMediumEnterprises #SmallBusiness #msmebusiness #startup #MSMEproject #MSMEs #MSMEStartUp #MSMEtrade #MicroSmallMediumEnterprises #IndiaStartUp #MSMEindustry
Plant capacity: -Plant & machinery: -
Working capital: -T.C.I: -
Return: 1.00%Break even: N/A
Add to Inquiry Add to Inquiry Basket

Active Pharma Ingredients (API) Amoxicillin Trihydrate, Azithromycin & Paracetamol

Active pharmaceutical ingredients are the active substances that are used in the manufacture of a drug and have a pharmacological effect. They provide health benefits and play a vital role in disease diagnosis, prevention, and treatment. Active pharmaceutical ingredients may be synthesized either chemically or through biotechnological methods. Azithromycin is used to treat certain bacterial infections, such as bronchitis; pneumonia; sexually transmitted diseases (STD); and infections of the ears, lungs, sinuses, skin, throat, and reproductive organs. Paracetamol is a commonly used medicine that can help treat pain and reduce a high temperature (fever). It is often recommended as one of the first treatments for pain, as it's safe for most people to take and side effects are rare. India is the seventh largest country in the world and has the second highest population. It has a parliamentary democratic form of government and has abundant natural resources and sufficient oil reserves. Huge investment promises from different countries predict a bright future for India. It has a well-developed administration and an independent judicial system with an ever-growing consumer base. It has a huge pool of hard-working skilled workers in all fields. The government has set up tax and non-tax incentives to establish new industrial entities in specific sectors, which include energy, ports, highways, electronics, and software. The Make in India initiative was launched by the government in 2014 and received an excellent response from the developed nations. The government has also created special areas dedicated to export, called export-processing zones (EPZs) or special economic zones (SEZs), to encourage foreign investment. The global active pharmaceutical ingredient market size is expected to reach a value of USD 286.6 billion by 2027, registering a CAGR of 6.7% over the forecast period. Factors, such as increasing preference for outsourcing APIs and growing prevalence of various target diseases such as cancer and Cardiovascular Diseases (CVDs) are expected to drive the market growth. Patent expirations of blockbuster drugs give rise to generic versions of these molecules, wherein the manufacturers bear the cost. After a patent expires, R&D investments done by the company are no longer beneficial for the company. API production requires a huge capital amount as the process needs extremely systematic protocols. Thus, pharmaceutical companies benefit from outsourcing API production, as it eliminates the need for labor force and installing expensive manufacturing units. Strategic outsourcing allows companies to focus on their core competencies, ultimately resulting in increased productivity. These factors are also projected to drive the active pharmaceutical ingredient market growth. The growth of active pharmaceutical ingredients market is marked by the huge demand for drugs like analgesics, anti-infectives and diabetes, and pain management drugs. But with the rising trend of increasing research and development (R&D) activities, the demand is experiencing a shift towards the advancement of complex APIs that find use in novel formulations, thereby targeting niche therapeutic areas. This facilitates the development of new technologies and ensures a high quality product. Among the problems for pharmaceutical supply chains during this pandemic are the restrictions and impact of COVID-19 on two of the largest global producers of active pharmaceutical ingredients (APIs) and generics: China and India. APIs is a crucial part of the pharma industry’s strategic plan to combat the COVID-19 pandemic. The majority of APIs for generic drug manufacturing across the globe are sourced from India, which also supplies approximately 30 percent of the generic APIs used in the US. However, Indian manufacturers rely heavily on APIs from China for the production of their medicine formulations, procuring around 70 percent from China, the top global producer and exporter of APIs by volume. Role of Government towards API The coronavirus outbreak disrupting supply of active pharmaceutical ingredients (APIs) and medical devices from China to India, the government has come out with four schemes worth Rs 13,760 crore to encourage manufacturing of bulk drugs and medical devices in the country and their exports. On March 21, the Union Cabinet under the chairmanship of Prime Minister Narendra Modi had approved an expenditure of Rs. 9,940 crore and Rs. 3,820 crore for APIs and medical devices, respectively. The Cabinet also approved a scheme on promotion of bulk drug parks for financing common infrastructure facilities in three bulk drug parks with financial implication of Rs. 3,000 crore for next five years. The government will give grants-in-aid to states with a maximum limit of Rs. 1,000 crore per bulk Drug Park. Parks will have common facilities such as solvent recovery plant, distillation plant, power and steam units, common effluent treatment plant etc. The government further approved production linked incentive (PLI) scheme for promotion of domestic manufacturing of critical KSMs/drug intermediates and APIs in the country with financial implications of Rs. 6,940 crore for next eight years. Financial incentive will be given to eligible manufacturers of identified 53 critical bulk drugs on their incremental sales over the base year (2019-20) for a period of 6 years. Out of 53 identified bulk drugs, 26 are fermentation based bulk drugs and 27 are chemical synthesis based bulk drugs. Rate of incentive will be 20 per cent (of incremental sales value) for fermentation based bulk drugs and 10 per cent for chemical synthesis based bulk drugs. The PLI scheme will lead to expected incremental sales of Rs. 46,400 crore and significant additional employment generation over eight years. The drug industry has welcomed the incentives offered by the government to promote API units in India. Besides APIs, the Cabinet also approved the scheme for promotion of medical device parks in the country in partnership with the states. A maximum grant-in-aid of Rs. 100 crore per park will be provided to the states. It will have financial implications of Rs. 400 crore. The PLI scheme for promoting domestic manufacturing of medical devices will have financial implications of Rs. 3,420 crore for next five years. Medical device is a growing sector and its potential for growth is the highest among all sectors in the healthcare market. It is valued at Rs. 50,026 crore for 2018-19 and is expected to reach to Rs. 86,840 crore by 2021-22. India depends on imports up to an extent of 85 per cent of total domestic demand of medical devices. Union Cabinet scheme on Promotion of Bulk Drug Parks • The scheme on Promotion of Bulk Drug Parks for financing Common Infrastructure Facilities in 3 Bulk Drug Parks with financial implication of Rs. 3,000 crore for next five years. • Production Linked Incentive (PLI) Scheme for promotion of domestic manufacturing of critical KSMs/Drug Intermediates and APIs in the country with financial implications of Rs6,940 crore for next eight years. Details: Promotion of Bulk Drug Parks • Decision is to develop 3 mega Bulk Drug parks in India in partnership with States. • Government of India will give Grants-in-Aid to States with a maximum limit of Rs. 1000 Crore per Bulk Drug Park. • Parks will have common facilities such as solvent recovery plant, distillation plant, power & steam units, common effluent treatment plant etc. • A sum of Rs. 3,000 crore has been approved for this scheme for next 5 years. Production Linked Incentive Scheme • Financial incentive will be given to eligible manufacturers of identified 53 critical bulk drugs on their incremental sales over the base year (2019-20) for a period of 6 years. • Out of 53 identified bulk drugs, 26 are fermentation based bulk drugs and 27 are chemical synthesis based bulk drugs. • Rate of incentive will be 20 % (of incremental sales value) for fermentation based bulk drugs and 10% for chemical synthesis based bulk drugs. • A sum of Rs. 6,940 crore has been approved for next 8 years. Few Indian major players are as under Alpha Remedies Ltd Ankur Drugs & Pharma Ltd. Cian Healthcare Ltd Farmson Pharmaceutical Gujarat Pvt. Ltd. Glaxosmithkline Pharmaceuticals Ltd. Pan Drugs Ltd Piramal Enterprises Ltd.
Plant capacity: Paracetamol : 1,000.0 Kgs / day Azithromycin : 500.0 Kgs / day Amoxicillin Trihydrate: 500.0 Kgs dayPlant & machinery: 175 lakhs
Working capital: -T.C.I: Cost of Project : Rs 1322 lakhs
Return: 29.00%Break even: 47.00%
Add to Inquiry Add to Inquiry Basket

Manufacturing of Active Pharma Ingredients (API) (Amoxicillin Trihydrate, Azithromycin & Paracetamol).

Production of Active Pharma Ingredients (API) (Amoxicillin Trihydrate, Azithromycin & Paracetamol). Investment Opportunities in Pharmaceutical Industry. An active ingredient (AI) is that the ingredient in an exceedingly pharmaceutical drug that's biologically active. The similar terms active pharmaceutical ingredient (API) and bulk active i.e. bulk medicine are utilized in medicine, and therefore the term active substance could also be used for natural products. Thus, depending on the drug’s administered dosage, the reactions and results differ. Certain drugs are comprised of more than one kind of API. Amoxicillin is an antibiotic used to treat variety of bacterial infections. These include middle ear infection, strep throat, pneumonia, skin infections, and tract infections among others. It’s taken orally, or less usually by injection. Active Pharmaceutical Ingredient (API), is that the term used to check with the biologically active component of a drug product (e.g. tablet, capsule). Drug products are typically composed of many elements. The aforementioned API is that the primary ingredient. Alternative ingredients are commonly known as "excipients" and these substances are always required to be biologically safe, often making up a variable fraction of the drug product. The procedure for optimizing and compositing this mixture of components utilized in the drug is known as "formulation." Paracetamol is a commonly used medicine that can help treat pain and reduce a high temperature (fever). It is often recommended as one of the first treatments for pain, as it's safe for most people to take and side effects are rare. Azithromycin is an antibiotic used for the treatment of variety of bacterial infections. This includes middle ear infections, strep throat, pneumonia, traveler's diarrhea, and bound alternative intestinal infections it also can be used for variety of sexually transmitted infections, as well as chlamydia and gonorrhea infections. At the side of alternative medications, it's going to even be used for malaria. It may be taken by mouth or intravenously with doses once per day. It is on the world Health Organization's List of Essential Medicines, the safest and most effective medicines required in a very health system. It’s one in all the most usually prescribed antibiotics in children. Trim ox is on the market as a generic medication. Related Books: - Pharmaceutical, Drugs, Proteins Technology Handbooks Azithromycin alone and in combination with different medications is currently being studied for the treatment of coronavirus wellness 2019 (COVID-19). Currently, azithromycin has been used with hydroxychloroquine to treat certain patients with COVID-19. However, there are mixed reports of effectiveness once azithromycin was used at the side of alternative medications to treat other viral respiratory infections. Azithromycin also has been used to treat bacterial infections in hospitalized patients with COVID-19. A lot of information is required before any conclusions may be made regarding the possible advantages and risks of using azithromycin either alone or together with hydroxychloroquine in patients with COVID-19. Amoxicillin Trihydrate may be a hydrate that's the Trihydrate type of amoxicillin; a semisynthetic antibiotic, used either alone or together with potassium clavulanate (under the name Augmentin) for treatment of a variety of bacterial infections. It’s a role as an antibacterial drug and an antimicrobial agent. It contains an amoxicillin. Manufacturing Process The manufacturing process of Paracetamol is summarized in the following steps: -charge acetic acid to the reactor. -add p-nitro phenol as a starting material and iron powder as catalyst. -Heat to temp 80-90 ºC. -The reaction is exothermic and temp will rise to 130 ºC. -After slight cooling -Reflux the reaction at 118ºC for 3-4 hours. -Cool to 60 ºC. -Add methanol to the reaction. -Reflux for 1 hour. -distill the methanol and recycle. -Add water to the obtained cake. -And make a solution -Add activated carbon. -Filter -Dry the cake. -Pulverize the dry cake to get the Paracetamol fine powder. Applications:- Communicable Diseases Oncology Diabetes Cardiovascular Diseases Pain Management Respiratory Diseases Other Therapeutic Applications Role of Government towards API The coronavirus outbreak disrupting supply of active pharmaceutical ingredients (APIs) and medical devices from China to India, the government has come out with four schemes worth Rs 13,760 crore to encourage manufacturing of bulk drugs and medical devices in the country and their exports. On March 21, the Union Cabinet under the chairmanship of Prime Minister Narendra Modi had approved an expenditure of Rs. 9,940 crore and Rs. 3,820 crore for APIs and medical devices, respectively. The Cabinet also approved a scheme on promotion of bulk drug parks for financing common infrastructure facilities in three bulk drug parks with financial implication of Rs. 3,000 crore for next five years. The government will give grants-in-aid to states with a maximum limit of Rs. 1,000 crore per bulk Drug Park. Parks will have common facilities such as solvent recovery plant, distillation plant, power and steam units, common effluent treatment plant etc. The government further approved production linked incentive (PLI) scheme for promotion of domestic manufacturing of critical KSMs/drug intermediates and APIs in the country with financial implications of Rs. 6,940 crore for next eight years. Financial incentive will be given to eligible manufacturers of identified 53 critical bulk drugs on their incremental sales over the base year (2019-20) for a period of 6 years. Out of 53 identified bulk drugs, 26 are fermentation based bulk drugs and 27 are chemical synthesis based bulk drugs. Rate of incentive will be 20 per cent (of incremental sales value) for fermentation based bulk drugs and 10 per cent for chemical synthesis based bulk drugs. The PLI scheme will lead to expected incremental sales of Rs. 46,400 crore and significant additional employment generation over eight years. The drug industry has welcomed the incentives offered by the government to promote API units in India. Besides APIs, the Cabinet also approved the scheme for promotion of medical device parks in the country in partnership with the states. A maximum grant-in-aid of Rs. 100 crore per park will be provided to the states. It will have financial implications of Rs. 400 crore. The PLI scheme for promoting domestic manufacturing of medical devices will have financial implications of Rs. 3,420 crore for next five years. Medical device is a growing sector and its potential for growth is the highest among all sectors in the healthcare market. It is valued at Rs. 50,026 crore for 2018-19 and is expected to reach to Rs. 86,840 crore by 2021-22. India depends on imports up to an extent of 85 per cent of total domestic demand of medical devices. Union Cabinet scheme on Promotion of Bulk Drug Parks • The scheme on Promotion of Bulk Drug Parks for financing Common Infrastructure Facilities in 3 Bulk Drug Parks with financial implication of Rs. 3,000 crore for next five years. • Production Linked Incentive (PLI) Scheme for promotion of domestic manufacturing of critical KSMs/Drug Intermediates and APIs in the country with financial implications of Rs6,940 crore for next eight years. Details: Promotion of Bulk Drug Parks • Decision is to develop 3 mega Bulk Drug parks in India in partnership with States. • Government of India will give Grants-in-Aid to States with a maximum limit of Rs. 1000 Crore per Bulk Drug Park. • Parks will have common facilities such as solvent recovery plant, distillation plant, power & steam units, common effluent treatment plant etc. • A sum of Rs. 3,000 crore has been approved for this scheme for next 5 years. Production Linked Incentive Scheme • Financial incentive will be given to eligible manufacturers of identified 53 critical bulk drugs on their incremental sales over the base year (2019-20) for a period of 6 years. • Out of 53 identified bulk drugs, 26 are fermentation based bulk drugs and 27 are chemical synthesis based bulk drugs. • Rate of incentive will be 20 % (of incremental sales value) for fermentation based bulk drugs and 10% for chemical synthesis based bulk drugs. • A sum of Rs. 6,940 crore has been approved for next 8 years. Market Outlook Active Pharmaceutical Ingredient Market is valued at USD 172.69 Billion in 2018 and expected to reach USD 263.80 Billion by 2025 with the CAGR of 6.24% over the forecast period. The increasing incidence of chronic diseases, growing importance of generics, and the increasing uptake of biopharmaceuticals are some of the major factors driving the growth of the global APIs market. On the other hand, the unfavorable drug price control policies across various countries and the increasing penetration of counterfeit drugs are expected to restrain the growth of this market in the coming years. Related Projects: - Pharmaceutical, Drugs, Fine Chemicals, Bulk Drug Intermediates Drugs and over-the-counter (OTC) drugs. In 2019, the prescribed drugs segment is expected to account for the most important share of the APIs market. The demand for drugs falling under this class has increased significantly in recent years because of the rising prevalence of target diseases. Additionally, the most important share of the prescription drugs segment also can be attributed to the increased focus of innovator corporations on the development of specialty drugs and affordability of health care. The implementation of significant federal reforms to improve the affordability of healthcare, especially in the, us has expanded the consumption of each traditional and specialty medicine. Also, inflation has played a key role in enhancing revenue from the sales of prescription drugs, significantly specialty drugs. All these factors are collectively responsible for the large share of this phase. Based on the kind of drug, the APIs market can be classified into two segments prescribed. Manufacturer Insights On the basis of type of manufacturer, the API market has been segmented into merchant and captive APIs. Captive API command the most important share in 2019 because of simple availability of raw materials and intensive capitalization of major key players for the development of high-end manufacturing facilities. API is calculable to be the fastest-growing segment over the forecast period. The segment growth is driven by factors similar to high cost of in-house manufacturing of those molecules and rising demand for biopharmaceuticals. Related Videos: - Pharmaceutical, Drugs, Fine Chemicals, Bulk Drug Intermediates, Pharmaceutical Drugs, Pharma Drug Ingredients Intermediates, Pharmaceutical Bulk Drugs Active Pharmaceutical Ingredient (APIs) are portions of any drugs that are biologically active in nature. The APIs have significant use in the manufacturing of effective and safe medicines. Depending on the drug’s administered dosage, the reactions and results take issue according to the requirement and use for specific treatment of diseases. Sure medicine are contained of over one kind of API. medicine are chosen primarily for his or her active ingredients to treat variety of chronic and infectious diseases similar to diabetes, cancer, arthritis, bone & joint infections, pneumonia, otitis, streptococcal pharyngitis, cellulites, and tract infections. However, the standard will vary widely from one whole to a different. Medicine are chosen primarily from active ingredients within the liquid or solid form like tablet or alternative throughout. Global Active Pharmaceutical Ingredient Market Dynamics The key issue for growth of worldwide Active Pharmaceutical Ingredient market is that the rise of demand for the new drug discovery for treatment of various chronic and infectious diseases like HIV, cancer, arthritis, bone & joint infections, hepatitis-B, Aids etc. across the world. According to WHO in 2018, the worldwide cancer burden has up to 18.1 million new cases as well as 9.6 million deaths across the world. Because of such rise within the cases of cancer, the new drugs discovery using the Active Pharmaceutical Ingredient has become essential. Recently in line with the American Chemical Society in 2019, there has been 48 new drugs has been approved by the fad U.S. out of that 11 for new cancer treatments with the innovative molecular pharmaceutical ingredients. However, the Active Pharmaceutical Ingredient market is hampered by would like for prime investment with huge capital demand for research and developments. Moreover rising health cautiousness among the people with technological advancement immense investment for launching of recent drugs and biological products, acquisitions, collaborations, and regional growth can provide huge opportunity for Active Pharmaceutical Ingredient market. For instance in 2019, Raquel has been acquired by Merck & Co. for roughly around USD 2.7 billion in cash, for making cancer drug using Active Pharmaceutical Ingredient with the most recent small-molecule-focused. Expansion of Manufacturing Facilities Creating Lucrative Opportunities for Market Growth Majority of specialty API companies are increasing their manufacturing facilities for specialty active pharmaceutical ingredients (API) to take care of or gain market share. Substantial investments within the growth of approved specialty active pharmaceutical ingredients (API) is one in all the most important factors among key players in the specialty active pharmaceutical ingredients (API) market. For instance, in early 2020, Wuxi STA opened oligonucleotide API manufacturing facility in Changzhou, China to cope up with the increasing demand. In 2018, Cordon Pharma expanded operations with new commercial oligonucleotide active pharmaceutical ingredients (API) manufacturing capabilities at its FDA inspected Colorado facility. The emergence of COVID-19 has brought the world to a standstill. We perceive that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies will help within the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost each sector is anticipated to be impacted by the pandemic. Focus on healthcare to drive the active pharmaceutical ingredients market The spending on healthcare has grown at a rapid pace in recent years and it increased at a CAGR of 6.92% between the years 2003 and 2013. The healthcare spending growth was significantly higher than the population growth rate that grew at a CAGR of 1.22% for the same period. The per capita healthcare spending rose from just under US$ 600 in 2003 to above US$ 1000 in 2013, at an average CAGR of 5.62%. The focus on healthcare spending was observed to be a global phenomenon and this directly benefited the active pharmaceutical ingredients market. Related Videos: - Active Pharma Ingredients (API) - Global Market Estimated to Reach US$ 21.9 billion by 2023 Investment Opportunities in API Bulk Drugs & Intermediates Manufacturing Unit Production of Paracetamol (Acetaminophen), bulk pharmaceutical active ingredient Investment Opportunities in APIs KSMs Drug Intermediates Bulk Drug Industries Manufacturing Business Ideas in Pharmaceutical Industry Key Players Pfizer, Inc. (US), Novartis AG (Switzerland), Sanofi (France), Boehringer Ingelheim (Germany), Bristol-Myers Squibb (US), Teva Pharmaceutical Industries Ltd. (Israel), Eli Lilly and Company (US), GlaxoSmithKline plc (UK), Merck & Co., Inc. (US), AbbVie Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), and AstraZeneca plc (UK). Sun Pharmaceutical Industries Ltd. Tags:- #Activepharmaingredients #pharmaingredients #IndianPharma #medicineingredients #paracetamolingredients #amoxicillinTrihydrate #Azithromycin #COVID19 #Paracetamol #coronavirus #CoronavirusBusiness #COVID2019 #CaronaBUSINESS #lockdownbusiness #businessinlockdown #coronavirusbusiness #Entrepreneurs #covid19business #DetailedProjectReport #businessconsultant #BusinessPlan #feasibilityReport #NPCS #industrialproject #entrepreneurindia #startupbusiness #startupbusinessideas #businessestostart #startupideas #startupbusinesswithnomoney #businessstartupindia #API
Plant capacity: -Plant & machinery: -
Working capital: -T.C.I: -
Return: 1.00%Break even: N/A
Add to Inquiry Add to Inquiry Basket

Manufacturing of Disposable Personal Protective Equipment (PPE) Kit.

Manufacturing of Disposable Personal Protective Equipment (PPE) Kit. Start Your Own Business With Huge Profits. Personal protective equipment (PPE) is equipment that will protect the user against health or safety risks at work. It can include items such as safety helmets, gloves, eye protection, high-visibility clothing, safety footwear and safety harnesses. It also includes respiratory protective equipment (RPE). PPE isn’t just limited to work, PPE is also used in sports and other recreational activities. These items include swimming goggles, football shin pads and rugby scrum caps. The purpose of PPE is to remove or reduce health and safety risks by imposing a barrier between the wearer and the potential risk. For example, an FFP3V Moulded Disposable Respirator will provide a barrier against very fine dust and mists to protect the wearer from the potential negative health impacts of breathing in dust such as crystalline silica, which can cause multiple lung diseases including silicosis. Related Videos: - Setting Up a Hospital in India. Investment Opportunity in Healthcare Industry. Protecting ourselves so that we can continue to help others, is a priority for health care providers around the world. This includes being conscious and up to date with infection prevention and control measures and the appropriate implementation of personal protective equipment (PPE), hand hygiene and waste management of potentially harmful materials. Why is PPE important? Health and safety risks cannot always be completely removed through other methods. There will always be jobs and tasks that have an element of risk to them, however, PPE can be used to reduce these risks to a reasonable and manageable level, and sometimes even completely remove them. Related Videos: - Setting Up a Hospital. Healthcare Business Ideas in Medical Sector Some tasks that would otherwise be completely unreasonable to complete can be made acceptable through the use of PPE. For example, using extremely loud machinery can significantly damage a person’s hearing. Exposure to noise levels of 110dB for more than 1 minute risks permanent hearing loss. Hearing protection can be used to make using loud equipment possible. Related Videos: - Business Opportunities in Health Care Sector for New Business Venture There is personal protective equipment which protects the individual from physical harm, such as blows to the body, bullets or headgear that prevents damage due to falling objects. There is respiratory personal protective equipment such as face masks and respirators, used to prevent exposure to substances like asbestos and dust or from pathogens such as anthrax and other pathogenic bacteria and viruses. Protective equipment can also extend to protective eyewear that can be used to protect the eyes from chemical splashes or solid objects, like dust particles. Ear protection also qualifies as PPE as does latex gloves, used in the scientific and medical industry to provide sterile exposure to patients or to keep pathogens from spreading via the hands. Types of PPE The types of PPE commonly used at facilities Include: • Safety glasses. • Chemical gloves. • Leather work gloves. • Safety goggles. • Chemical apron. • Hearing protection. • Hard hat. Related Books: - Disposable Products (Medical, Surgical, Thermocol, Plastic, Paper, Domestic And General Products) Market Outlook Besides the need for PPE for healthcare professionals focusing on developing a vaccine for the lethal virus, there is also an urgent need for protective equipment manufacturers to develop and introduce safer and more cost-effective products in the market. Among the types of personal protective equipment required for healthcare professionals dealing with coronavirus, four major types include isolation gowns, respirators, gloves, and face masks. Healthcare-related organizations and respective regulatory bodies are working toward improving the safety standards and awareness related to the effects of COVID-19 in their respective countries. Such efforts will fuel the demand for personal protective equipment and enhance the revenue growth of the global personal protective equipment market. Related Projects: - Healthcare and Medical Businesses The manufacturing segment involves several risky operations such as grading, excavating, trenching, digging, boring, drilling, blasting, and concreting. In the manufacturing industry, personal protective equipment are used in production of chemicals, electronics, pulp & paper, metal fabrication, steel, wood, and glass, among others. Different types of personal protective equipment required in the manufacturing industry include hands & arm protection, eye & face protection, protective clothing, hearing protection, and head protection. The rapidly increasing number of COVID-19 cases globally has resulted in an insufficient supply of healthcare personal protective equipment, especially respirators and masks. In addition, the supply for protective clothing and face and eye protection used by healthcare professionals is likely to be exhausted owing to the increased demand for personal protective equipment. Related Videos: - Services Sector, Healthcare Industry, Hospitality Sector, Education Sector, Advertising and Automobile Workshop, Leisure and Entertainment Industry The disposable protective clothing market is expected to grow by USD 1.23 billion during 2020-2024. The number of people infected with COVID-19 has seen a surge in most of the countries including the US, Italy, Spain, France, the UK, Germany, and the Netherlands. This is driving the demand for disposable coverall, facemasks, and gloves, which is expected to fuel the growth of the disposable protective clothing market. Furthermore, all these patients along with healthcare workers and people all over the world are required to be provided by personal protective equipments as fast as possible to deal with this global pandemic. Moreover, the organization states that with the emergence of COVID-19 many other repercussions could prevail such as seroepidemiological problem, biological and clinical characteristics along with epidemiological issues of the virus and associated disease. Additionally, in order to combat this situation rapid development of personal protective equipment is extremely vital that is significantly contributing towards the growth of the global personal protective equipment market. Currently, India has about 15.96 lakh PPE kits in the centre-state buffer stock and orders for another 2.22 crore PPE kits have already been placed to domestic manufacturers. The Indian textile manufacturing industry came to the fore in this exercise, where they initially began with manufacturing of masks followed by complete PPE sets, including body coveralls, gloves, shoe covers, etc. The textile sector is gearing up to start producing these goods, which comes under the medical textiles segment, with a view to making India a hub for sourcing of PPE kits over the next few years. Production of PPE is proving to be a commercially viable product category and a savior in this time of crisis wherein economic uncertainties loom large owing to the effects of the nationwide lockdown. Related Videos: - Business Ideas after the Covid Breakdown Now, the domestic production of PPE in India is being currently pegged at about 4.5 lakh PPE kits per day. This mammoth growth has been achieved owing to domestic manufacturers who rose to the occasion and helped India attain a self-sufficient status in the production of PPE. Personal Protective Equipment in India: An INR 7,000 Cr industry in the making The COVID-19 pandemic is the defining global health crisis that the world is currently facing. The virus has spread all over the world, and the number of cases is rising every single day as governments work to slow its spread. The global response to the unfolding COVID-19 crisis saw countries implementing countrywide or partial lockdowns, the announcement of stimulus packages and relief measures to tackle the harsh economic impact of the pandemic. The virus also overwhelmed the global production capacity of PPE which is the most critical product to protect the front-line health workers and other responders. Surging demand for PPE kits along with disrupted global supply chain amid the Covid-19 pandemic was putting lives at risk. India moved quickly, implementing a nationwide lockdown with the goal of flattening the curve and using the time to plan resource responses, adequately. The Prime Minister assured the country that there are ample reserves of medicines, PPE kits, food and other essential goods. India realized the critical role of PPE in combating this pandemic as early as March, wherein the Ministry of Textiles stepped to lead the assessment of the availability of all protective wears for our frontline health workers. Related Projects: - Business Ideas after the Covid Breakdown What followed this, is a remarkable journey of collaboration between governments at the central and state levels, industries and workers to revamp existing production lines to manufacture a completely unknown product, from scratch. ? From 0, India now produces nearly 4.5 lakh PPE kits every single day. ? In 60 days, the PPE industry in India has witnessed 56 times growth. This is a testimony to the government of India’s concerted efforts of improving domestic manufacturing capacity on the back of its industrious manufacturing sector at such challenging times. Defence Research and Development Organization (DRDO) DRDO best known for its self-developed line of nuclear-capable missiles that has given India its strategic deterrence, reoriented itself to mobilize its existing skills and resources to create spin-off technologies to help in the production of critical products. With the support of the science fraternity, several products to combat the pandemic including ventilators, PPE kits, large area sanitization solutions and Covid-19 sample collection kiosks have been developed. PPE kits are sent to DRDO for testing by HLL Life care, which is the government’s nodal agency for medical procurement. Pressure testing of these kits are done at six different levels and only after passing such stringent quality tests, they are sent for distribution. The South Indian Textile Research Association (SITRA), Coimbatore SITRA is the centre of excellence for medical textiles at Coimbatore, Tamil Nadu. Established in the year 1956, SITRA is governed by a council of administration consisting of member representatives of the industry, government and scientists. SITRA is sponsored by the industry and is supported by the Ministry of Textiles. SITRA spearheaded the testing for body coveralls as early as March by upgrading itself with PPE testing facility. Key Players 3M Co. (US), MSA Safety Inc. (US), Ansell Limited (US), Honeywell International Inc. (US), E I du Pont de Nemours and Co. (US), Kimberly-Clark Corporation (US), Lakeland Industries, Inc. (US), Alpha Pro Tech, Ltd. (Canada), Sioen Industries NV (Belgium), and Radians, Inc. (US), Tags:- #PersonalProtectiveEquipment #PPE #CoronavirusBusiness #COVID2019 #caronavirrus #CaronaBUSINESS #lockdownbusiness #COVID #businessinlockdown #coronavirusbusiness #Entrepreneurs #covid19business #DetailedProjectReport #businessconsultant #BusinessPlan #feasibilityReport #NPCS #industrialproject #entrepreneurindia #startupbusiness #startupbusinessideas #businessestostart #startupideas #startupbusinesswithnomoney #businessstartupindia
Plant capacity: -Plant & machinery: -
Working capital: -T.C.I: -
Return: 1.00%Break even: N/A
Add to Inquiry Add to Inquiry Basket

Information
  • One Lac / Lakh / Lakhs is equivalent to one hundred thousand (100,000)
  • One Crore is equivalent to ten million (10,000,000)
  • T.C.I is Total Capital Investment
  • We can modify the project capacity and project cost as per your requirement.
  • We can also prepare project report on any subject as per your requirement.
  • Caution: The project's cost, capacity and return are subject to change without any notice. Future projects may have different values of project cost, capacity or return.

Add multiple items to inquiry
Select the items and then press Add to inquiry button

Page 131 of 221 | Total 2201 projects in this category
« Previous   Page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 .... 131 220 221   Next »

About NIIR PROJECT CONSULTANCY SERVICES

Hide »

NIIR PROJECT CONSULTANCY SERVICES (NPCS) is a reliable name in the industrial world for offering integrated technical consultancy services. NPCS is manned by engineers, planners, specialists, financial experts, economic analysts and design specialists with extensive experience in the related industries.

Our various services are: Detailed Project Report, Business Plan for Manufacturing Plant, Start-up Ideas, Business Ideas for Entrepreneurs, Start up Business Opportunities, entrepreneurship projects, Successful Business Plan, Industry Trends, Market Research, Manufacturing Process, Machinery, Raw Materials, project report, Cost and Revenue, Pre-feasibility study for Profitable Manufacturing Business, Project Identification, Project Feasibility and Market Study, Identification of Profitable Industrial Project Opportunities, Business Opportunities, Investment Opportunities for Most Profitable Business in India, Manufacturing Business Ideas, Preparation of Project Profile, Pre-Investment and Pre-Feasibility Study, Market Research Study, Preparation of Techno-Economic Feasibility Report, Identification and Selection of Plant, Process, Equipment, General Guidance, Startup Help, Technical and Commercial Counseling for setting up new industrial project and Most Profitable Small Scale Business.

NPCS also publishes varies process technology, technical, reference, self employment and startup books, directory, business and industry database, bankable detailed project report, market research report on various industries, small scale industry and profit making business. Besides being used by manufacturers, industrialists and entrepreneurs, our publications are also used by professionals including project engineers, information services bureau, consultants and project consultancy firms as one of the input in their research.

^ Top